Literature DB >> 1172850

Evaluation of an anti-infective combination. Trimethoprim-sulfamethoxazole (Bactrim, Septra).

D O Schiffman.   

Abstract

Trimethoprim and sulfamethoxazole, combined in a synthetic anti-infective preparation, act synergistically to inhibit the growth of certain microorganisms. This combination is effective orally in acute and chronic urinary tract infections. It also has been used successfully to treat other infectious conditions, including bacterial upper respiratory tract infections, ear infections, skin and soft-tissue infections, septicemias, acute and subacute bacterial endocarditis, enteric fever, brucellosis, prostatitis, and gonorrhea. It is well tolerated by most patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1172850

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Neonatal brucellosis.

Authors:  M M Lubani; K I Dudin; D C Sharda; N M Abu Sinna; T Al-Shab; A A Al-Refe'ai; S M Labani; A Nasrallah
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

2.  Efficacy of co-trimoxazole in Donovanosis. A preliminary report.

Authors:  B R Garg; S Lal; S Sivamani
Journal:  Br J Vener Dis       Date:  1978-10

3.  Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Authors:  Mario Sánchez-Borges; Bernard Thong; Miguel Blanca; Luis Felipe Chiaverini Ensina; Sandra González-Díaz; Paul A Greenberger; Edgardo Jares; Young-Koo Jee; Luciana Kase-Tanno; David Khan; Jung-Won Park; Werner Pichler; Antonino Romano; Maria José Torres Jaén
Journal:  World Allergy Organ J       Date:  2013-10-31       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.